[cmsSlot cmsName="audio_emb114" cmsParams=""][/cmsSlot] This week we catch up with the chief exterior designer for Scout Motors, Taylor Langhals, who explains how Scout took a 1960s and '70s icon and ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

It has been a tough period for CSL Ltd (ASX: CSL) shares. The biotechnology giant's shares ended the week at $143.19, which leaves them trading close to multi-year lows. Is this an opportunity to ...

CSL has said that with flu jab rates in the US down between 12% and 14% this year, it has decided to delay the planned spinout of its Seqirus vaccines business and cut its profit forecast for the ...

CSL Behring's Andembry can be used to prevent recurrent attacks of hereditary angioedema (HAE) by the NHS, according to finalised guidance from reimbursement authority NICE. The just-published ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

If you're a fan of racing games like Gran Turismo 7, you might be missing out on the full experience if you're only using a standard controller. While controllers are great for a lot of games, ...

CSL cut its company-wide full-year revenue guidance to 2% to 3% growth. — Reuters SYDNEY: Australian biotech CSL yesterday has delayed its planned vaccine division spin-off and cut earnings forecasts ...

CSL began in Victoria in 1916. How would you describe the company today? CSL is a leading global biotechnology company with a portfolio of life-saving medicines for patients with rare and serious ...